Dr. Mark W. Munro, MD

Dr. Munro practices at Orlando Health Physician Group Inc in Orlando, Florida.

Dr. Munro's NPI, 1295705127, was assigned on January 24, 2006. Dr. Munro graduated from Penn State College of Medicine in 1998. Dr. Munro holds Florida license ME87118.

Dr. Munro's primary practice is Orlando Health Physician Group Inc, at 1222 S Orange Ave, Orlando, FL 32806 in Orange County. The practice phone is (321) 843-4690.

Dr. Munro's primary practice is Orlando Health Physician Group Inc in Orlando, Florida. Dr. Munro is also affiliated with AdventHealth Orlando. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Munro to 4 more hospitals, 5 group practices and clinics, 5 home health agencies and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Munro practices, 15 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Munro's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Munro is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Munro's licenses on file in 3 states: Florida, West Virginia and Pennsylvania.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, bursitis, hand joint or tendon inflammation, hip replacement, joint pain, knee arthroscopy and knee injury among the conditions Dr. Munro treats.

CMS data shows 1,351 Medicare services from Dr. Munro across 19 procedure codes in 2024, for 433 Medicare patients. Medicare paid $147,870 for them.

CMS counts 433 Medicare patients who saw Dr. Munro in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Munro's median patient age at 72, with 62% women.

In 2024, Dr. Munro wrote 222 Medicare Part D claims for 146 patients. 99% of them were for generic drugs. CMS names the drug for 166 of them, across 6 drugs with 11 or more claims each, at $2,385 in total drug cost. In 2023, CMS named 220 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Munro for performance year 2024, reported as part of a group. Dr. Munro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 48 procedures of hip replacement by Dr. Munro, more than 86% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Upper limb (arm) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Munro, published from 2008 to 2023. The most frequent topics are Fractures, Bone, Acetabulum and Femur. Dr. Munro has published most often in Bull Hosp Jt Dis (2013). Dr. Munro's most frequent co-authors are Joshua R. Langford, MD, George John Haidukewych, MD and Frank Roman Avilucea, MD.

CMS Open Payments shows 184 general payments to Dr. Munro from 34 drug and device companies from 2016 to 2025. Accredited education speaker fees make up the largest share, 25% of the total. Maxx Orthopedics, Inc. paid the most, $307,773.

Dr. Munro graduated from Penn State College of Medicine in 1998.

Dr. Munro is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.